Nektar Therapeutics | NKTR - Umsatzerlöse





Der Umsatz Veränderung Datum
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
ALKERMES USD 496.01M 103.1M 2026-06
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amgen USD 10.1B 1.48B 2026-06
Baxter International USD 2.96B 260M 2026-06
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Biogen USD 2.74B 490M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cipla INR 71.19B 5.78B 2026-06
Dr.Reddys Laboratories INR 80.71B 5.25B 2026-06
Eisai JPY 234.33B 28.9B 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Exelixis USD 628.69M 17.89M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Grifols EUR 2B 306.7M 2026-03
Halozyme Therapeutics USD 481M 104M 2026-06
Incyte USD 1.67B 400M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Ironwood Pharmaceuticals USD 113.04M 6.53M 2026-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
Merck USD 16.6B 310M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 959M 148M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Pfizer USD 15.03B 530M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Takeda JPY 1.22T 130B 2026-06
Teva Pharmaceutical Industries USD 12.67B 900M 2026-06
Xencor USD 51.22M 46.71M 2026-06